12 results
10-K/A
2022 FY
STSA
Satsuma Pharmaceuticals Inc
28 Apr 23
Annual report (amended)
4:08pm
believe that Mr. Kollins extensive leadership and operating experience in the pharmaceutical and biopharmaceutical industry, including experience … believe that Mr. King’s extensive leadership experience in the pharmaceutical and biopharmaceutical industry, including experience with small
DEF 14A
STSA
Satsuma Pharmaceuticals Inc
24 Apr 20
Definitive proxy
4:14pm
of the Board of Directors
Leadership Structure of the Board
Role of Board in Risk Oversight Process
Board Committees
Compensation Committee Interlocks … believe that Mr. Kollins extensive leadership experience in the pharmaceutical and biopharmaceutical industry, including experience consulting
8-K
EX-99.1
eix83jtvmhby sgtfp
10 Mar 20
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Results
4:10pm
424B4
78ny4ff2e9c8i9qt4zx
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
55znyv6 3df
3 Sep 19
IPO registration (amended)
6:12am
S-1
6e67uww
16 Aug 19
IPO registration
5:15pm
DRS/A
16ty0e0z94mz4nd49
2 Aug 19
Draft registration statement (amended)
12:00am
DRS
jk8 uf43m
21 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next